Silver Book Fact

To date, multiple genomewide comparisons of thousands of subjects with type 2 diabetes and controls without the disease have identified approximately twenty-five DNA variants that are significantly associated with type 2 diabetes. 

Spiegel, Allen M. and Meredith Hawkins. ‘Personalized Medicine’ To Identify Genetic Risks For Type 2 Diabetes And Focus Prevention: Can It Fulfill Its Promise?. Health Affairs. 2012; 31(1): 43-49. https://www.healthaffairs.org/doi/abs/10.1377/hlthaff.2011.1054?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed

Reference

Title
‘Personalized Medicine’ To Identify Genetic Risks For Type 2 Diabetes And Focus Prevention: Can It Fulfill Its Promise?
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2012
Authors
Spiegel, Allen M. and Meredith Hawkins
Volume & Issue
Volume 31, Issue 1
Pages
43-49
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • New and emerging technologies have made it easier for people with diabetes to manage their disease. Improved technology came in the form of a continuous glucose monitor, first approved by…  
  • The cost effectiveness ratio for pump therapy compared with daily insulin injections is about $18,000 per life year saved.  
  • Anti-VEGF Letter Improvement
    An anti-VEGF therapy for DME improved vision by more than 15 letters in approximately 36-51% of participants in a trial.  
  • Improved control of cholesterol or blood lipids, can reduce diabetic complications by 20-50%.  
  • Therapy that keeps blood glucose levels as close to normal as possible in type 1 diabetics, reduces damage to the eyes by 76%. Experts believe that these results can…